These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38076664)

  • 41. Low-dose ketamine infusion in treatment-resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment-resistant depression.
    Chen MH; Wu HJ; Li CT; Lin WC; Tsai SJ; Hong CJ; Tu PC; Bai YM; Mao WC; Su TP
    Hum Psychopharmacol; 2022 Mar; 37(2):e2820. PubMed ID: 34597436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
    Hilton RC; Rengasamy M; Mansoor B; He J; Mayes T; Emslie GJ; Porta G; Clarke GN; Wagner KD; Birmaher B; Keller MB; Ryan N; Shamseddeen W; Asarnow JR; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2013 May; 52(5):482-92. PubMed ID: 23622849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial.
    Correia-Melo FS; Leal GC; Carvalho MS; Jesus-Nunes AP; Ferreira CBN; Vieira F; Magnavita G; Vale LAS; Mello RP; Nakahira C; Argolo FC; Cardoso T; Souza CDS; Fontes ATC; Ferreira MB; Araújo-de-Freitas L; Tuena MA; Echegaray MVF; Cavalcanti DE; Lucchese AC; Bandeira ID; Telles M; Lima CS; Sampaio AS; Silva SS; Marback RF; Del-Porto JA; Abreu JN; Sarin LM; Paixão CS; Carvalho LP; Machado PRL; Turecki G; Lacerda ALT; Quarantini LC
    Medicine (Baltimore); 2018 Sep; 97(38):e12414. PubMed ID: 30235716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial.
    McAllister-Williams RH; Anderson IM; Finkelmeyer A; Gallagher P; Grunze HC; Haddad PM; Hughes T; Lloyd AJ; Mamasoula C; McColl E; Pearce S; Siddiqi N; Sinha BN; Steen N; Wainwright J; Winter FH; Ferrier IN; Watson S;
    Lancet Psychiatry; 2016 Feb; 3(2):117-27. PubMed ID: 26727041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ketamine-Associated Change in Anhedonia and mTOR Expression in Treatment-Resistant Depression.
    Singh B; Vande Voort JL; Riva-Posse P; Pazdernik VM; Frye MA; Tye SJ
    Biol Psychiatry; 2023 Jun; 93(12):e65-e68. PubMed ID: 36707268
    [No Abstract]   [Full Text] [Related]  

  • 46. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 47. Suicidality in treatment resistant depression: perspective for ketamine use.
    Jakuszkowiak-Wojten K; Gałuszko-Węgielnik M; Wilkowska A; Słupski J; Włodarczyk A; Górska N; Szarmach J; Szałach ŁP; Wiglusz MS; Krysta K; Cubała WJ
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):258-260. PubMed ID: 31488737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. L-methylfolate Augmentation to Antidepressants for Adolescents with Treatment-Resistant Depression: A Case Series.
    Dartois LL; Stutzman DL; Morrow M
    J Child Adolesc Psychopharmacol; 2019 Jun; 29(5):386-391. PubMed ID: 31058543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults.
    MacQueen G; Santaguida P; Keshavarz H; Jaworska N; Levine M; Beyene J; Raina P
    Can J Psychiatry; 2017 Jan; 62(1):11-23. PubMed ID: 27554483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid antisuicidal effects of prolonged iTBS on treatment-resistant depression: A case report.
    Tien Y; Huang CW; Chan CH
    Psychiatry Res; 2021 Nov; 305():114264. PubMed ID: 34752989
    [No Abstract]   [Full Text] [Related]  

  • 51. Using mechanism of action to choose medications for treatment-resistant depression.
    Thase ME; Schwartz TL
    J Clin Psychiatry; 2015 Sep; 76(9):e1147. PubMed ID: 26455685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of Psychedelics in Treatment-Resistant Depression.
    Kamal S; Jha MK; Radhakrishnan R
    Psychiatr Clin North Am; 2023 Jun; 46(2):291-305. PubMed ID: 37149346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rodent models of treatment-resistant depression.
    Caldarone BJ; Zachariou V; King SL
    Eur J Pharmacol; 2015 Apr; 753():51-65. PubMed ID: 25460020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [ESKETAMINE FOR TREATMENT RESISTANT DEPRESSION: RESEARCH AND RISK MANAGEMENT].
    Marom A; Rosca P
    Harefuah; 2021 Jun; 160(6):372-376. PubMed ID: 34160154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression.
    Gukasyan N
    Med; 2023 Jan; 4(1):8-9. PubMed ID: 36640755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The use of psilocybin for treatment-resistant depression].
    Johannesdottir A; Sigurdsson E
    Laeknabladid; 2022 Sep; 108(9):403-410. PubMed ID: 36040772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Esketamine (Spravato) for Treatment-Resistant Depression.
    Jalloh M
    Am Fam Physician; 2020 Mar; 101(6):339-340. PubMed ID: 32163257
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment-Resistant Depression in Adolescents: Clinical Features and Measurement of Treatment Resistance.
    Strawn JR; Aaronson ST; Elmaadawi AZ; Schrodt GR; Holbert RC; Verdoliva S; Heart K; Demitrack MA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2020 May; 30(4):261-266. PubMed ID: 32315537
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment-Resistant Depression in Older Adults.
    Steffens DC
    N Engl J Med; 2024 Feb; 390(7):630-639. PubMed ID: 38354142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression.
    McCarthy MJ; Chen Y; Demodena A; Leckband SG; Fischer E; Golshan S; Suppes T; Kelsoe JR
    J Psychopharmacol; 2021 Aug; 35(8):992-1002. PubMed ID: 33938307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.